Company continues toward the initiation of its Phase 1 Clinical Trial in AML for CER-1236
CERo Therapeutics Holdings, Inc. Announces Progress in Initiation of Phase 1 Clinical Trial by Executing an Agreement with Contract Research Organization CellCarta to Manage Translational Assays
Seeking Alpha / 1 hour from now 1 Views
Comments